Publications by authors named "Ruth Board"

Claim this Profile
A
A qualitative study exploring the perceptions and understandings of advance care planning by people with treatable but not curable cancer.
Ruth Board, Sean Hughes, Katherine Stewart, Tomoko Lewis, Sheila Payne

Palliat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Impact of Low-Grade Toxicities to Adjuvant Pembrolizumab in Stage III Melanoma.
Nasreen Abdul Aziz, David Burke, Waleed Khalifa, Sharanniyan Ragavan, Ruth Board

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Real-World Impact of Low-Grade Toxicities to Adjuvant Pembrolizumab in Stage III Melanoma.
Nasreen Abdul Aziz, David Burke, Waleed Khalifa, Sharanniyan Ragavan, Ruth Board

JCO Oncol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine-learning based classification of 2D-IR liquid biopsies enables stratification of melanoma relapse risk.
Kelly Brown, Amy Farmer, Sabina Gurung, Matthew J Baker, Ruth Board

Chem Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing research collaborations and building capacity in palliative and end-of-life care in the North West Coast of England: the PalCaRe-NWC partnership.
Lesley Dunleavy, Ruth Board, Seamus Coyle, Andrew Dickman, John Ellershaw

Public Health Res (Southampt)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why are organisational approvals needed for low-risk staff studies in the UK? Procedures, barriers, and burdens.
Lesley Dunleavy, Ruth Board, Seamus Coyle, Andrew Dickman, John Ellershaw

BMC Health Serv Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding barriers and facilitators to palliative and end-of-life care research: a mixed method study of generalist and specialist health, social care, and research professionals.
Catherine Walshe, Lesley Dunleavy, Nancy Preston, Sheila Payne, John Ellershaw, Ruth Board

BMC Palliat Care· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas, Karla A Lee, Niccolo Rossi, Ruth Board

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF mutant advanced melanoma (INTERIM).
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, Jenny Nobes, Ruth Board

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.
Ishan Mehta, Alimu Dayimu, Satish Kumar, Clare Boobier, Olabode Oladipo, Ruth Board

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma.
Laura A Bolte, Karla A Lee, Johannes R Björk, Emily R Leeming, Marjo J E Campmans-Kuijpers, Ruth Board

JAMA Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Get Data Out' Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England.
Birgitta van Bodegraven, Sally Vernon, Charlotte Eversfield, Ruth Board, Paul Craig

Br J Dermatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.
Alessia Visconti, Niccolò Rossi, Helena Deriš, Karla A Lee, Maja Hanić, Ruth Board

BMC Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma.
Niccolò Rossi, Karla A Lee, Maria V Bermudez, Alessia Visconti, Andrew Maltez Thomas, Ruth Board

EBioMedicine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.
Karla A Lee, Andrew Maltez Thomas, Laura A Bolte, Johannes R Björk, Laura Kist de Ruijter, Ruth Board

Nat Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A guideline for the outpatient management of glycaemic control in people with cancer.
Nalinie Joharatnam-Hogan, Pinkie Chambers, Ketan Dhatariya, Ruth Board,

Diabet Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study.
Stéphane Dalle, Laurent Mortier, Pippa Corrie, Michal Lotem, Ruth Board

BMC Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018.
Ruth Board, Rebecca Smittenaar, Sarah Lawton, Hanhua Liu, Bukky Juwa

Int J Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid analysis of disease state in liquid human serum combining infrared spectroscopy and "digital drying".
Alexandra Sala, Katie E Spalding, Katherine M Ashton, Ruth Board, Holly J Butler

J Biophotonics· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ano-uro-genital mucosal melanoma UK national guidelines.
Henry G Smith, Izhar Bagwan, Ruth E Board, Sharon Capper, Sarah E Coupland

Eur J Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less is more: A systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanoma.
Henry G Smith, Jessica Glen, Nancy Turnbull, Howard Peach, Ruth Board

Eur J Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer control in low- and middle-income countries: time for action.
Berkin Hack, Katy Piddock, Susannah Stanway, Kirsty Balachandran, Ruth Board

J R Soc Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab-induced Sarcoid-like Reactions during Treatment of Metastatic Melanoma.
Sophie C Cheshire, Ruth E Board, Alexandra R Lewis, Laxminarayan D Gudur, Michael J Dobson

Radiology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with pembrolizumab toxicities in advanced melanoma patients: a single-center experience in the UK.
Alfred Cp So, Ruth E Board

Melanoma Manag· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis